CA AB2115

Authorizes practitioners at nonprofit or free clinics to dispense narcotic drugs from clinic supply to relieve acute withdrawal symptoms while arranging referral for treatment, subject to specific reporting, labeling, and recordkeeping requirements.

Requires clinics dispensing narcotic drugs to establish policies for patient assessment, treatment appropriateness evaluation, connecting patients to ongoing opioid use disorder treatment, and limiting dispensing to prevent renewal or extension.

Permits practitioners to directly dispense up to a 3-day supply of Schedule II controlled substances for initiating maintenance or detoxification treatment for opioid use disorder, in addition to existing 72-hour supply provisions.

Directs the State Department of Health Care Services to amend narcotic treatment program regulations by April 30, 2029, to comply with federal regulations published February 2, 2024 (89 FR 7528).

Removes LEVO-alpha-acetylmethadol (LAAM) from authorized medications for narcotic replacement therapy and simplifies legislative intent regarding take-home doses by removing the requirement that daily clinic attendance be incompatible with employment or education.